You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 29, 2025

CLINICAL TRIALS PROFILE FOR MAGNESIUM SULFATE IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for MAGNESIUM SULFATE IN PLASTIC CONTAINER

Trial IDTitleStatusSponsorPhaseStart DateSummary
NCT00007033 ↗ Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease Completed Children's Hospital Medical Center, Cincinnati N/A 2000-10-01 OBJECTIVES: I. Determine the role of magnesium deficiency in the pathogenesis of decreased serum vitamin D and reduced bone density in children with chronic cholestatic liver disease.
NCT00004730 ↗ Magnesium Sulfate For Brain Injury Completed University of Washington Phase 3 1998-08-01 The purpose of the study is to determine whether magnesium sulfate, given within 8 hours of a moderate or severe traumatic brain injury improves survival, decreases the number of people developing seizures, improves the survivors' mental and psychological functioning, including the ability to return to daily life, live independently, and return to work or school.
NCT00004399 ↗ Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia Completed University of Utah N/A 1995-09-01 OBJECTIVES: I. Determine the effectiveness of nimodipine versus magnesium sulfate in the prevention of eclamptic seizures in patients with severe preeclampsia.
NCT00004399 ↗ Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia Completed FDA Office of Orphan Products Development N/A 1995-09-01 OBJECTIVES: I. Determine the effectiveness of nimodipine versus magnesium sulfate in the prevention of eclamptic seizures in patients with severe preeclampsia.
NCT00002146 ↗ Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study Completed Astra USA Phase 4 1969-12-31 To determine whether acute ionized hypomagnesemia and hypocalcemia immediately following foscarnet infusions can be lessened or eliminated by prior infusion of magnesium sulfate. To determine whether reductions in ionized magnesium, ionized calcium, and parathyroid hormone levels following foscarnet infusions are lessened by preinfusion of magnesium sulfate. To evaluate the safety of intravenous magnesium sulfate prior to foscarnet infusion by monitoring blood pressure, heart rate, and heart rhythm. To characterize the effect of magnesium sulfate on foscarnet blood levels and urinary excretion of calcium, magnesium, phosphate, and foscarnet.
>Trial ID>Title>Status>Phase>Start Date>Summary
Showing 1 to 5 of 5 entries

Clinical Trial Conditions for MAGNESIUM SULFATE IN PLASTIC CONTAINER

Condition Name

211111100-20246810121416182022Postoperative PainMagnesium SulfatePreeclampsiaAsthma[disabled in preview]
Condition Name for MAGNESIUM SULFATE IN PLASTIC CONTAINER
Intervention Trials
Postoperative Pain 21
Magnesium Sulfate 11
Preeclampsia 11
Asthma 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

3726171600510152025303540Pain, PostoperativePre-EclampsiaObstetric Labor, PrematureAsthma[disabled in preview]
Condition MeSH for MAGNESIUM SULFATE IN PLASTIC CONTAINER
Intervention Trials
Pain, Postoperative 37
Pre-Eclampsia 26
Obstetric Labor, Premature 17
Asthma 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for MAGNESIUM SULFATE IN PLASTIC CONTAINER

Trials by Country

+
Trials by Country for MAGNESIUM SULFATE IN PLASTIC CONTAINER
Location Trials
United States 130
Egypt 84
Korea, Republic of 18
Brazil 17
Canada 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

+
Trials by US State for MAGNESIUM SULFATE IN PLASTIC CONTAINER
Location Trials
California 13
New York 9
Ohio 9
Pennsylvania 8
Illinois 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for MAGNESIUM SULFATE IN PLASTIC CONTAINER

Clinical Trial Phase

42.3%22.2%11.9%23.7%020304050607080Phase 4Phase 3Phase 2/Phase 3[disabled in preview]
Clinical Trial Phase for MAGNESIUM SULFATE IN PLASTIC CONTAINER
Clinical Trial Phase Trials
Phase 4 82
Phase 3 43
Phase 2/Phase 3 23
[disabled in preview] 46
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

48.5%19.0%15.7%16.7%0405060708090100110120130140150CompletedRecruitingNot yet recruiting[disabled in preview]
Clinical Trial Status for MAGNESIUM SULFATE IN PLASTIC CONTAINER
Clinical Trial Phase Trials
Completed 148
Recruiting 58
Not yet recruiting 48
[disabled in preview] 51
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MAGNESIUM SULFATE IN PLASTIC CONTAINER

Sponsor Name

trials05101520253035Assiut UniversityCairo UniversitySeoul National University Bundang Hospital[disabled in preview]
Sponsor Name for MAGNESIUM SULFATE IN PLASTIC CONTAINER
Sponsor Trials
Assiut University 33
Cairo University 17
Seoul National University Bundang Hospital 13
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

93.4%0050100150200250300350400OtherNIHIndustry[disabled in preview]
Sponsor Type for MAGNESIUM SULFATE IN PLASTIC CONTAINER
Sponsor Trials
Other 394
NIH 13
Industry 12
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Magnesium Sulfate in Plastic Containers: Clinical Trials, Market Analysis, and Projections

Introduction

Magnesium sulfate, a versatile compound with widespread applications in medicine, agriculture, and other industries, is increasingly being packaged in plastic containers for convenience and safety. Here, we delve into the current state of clinical trials, market analysis, and future projections for magnesium sulfate in plastic containers.

Clinical Trials and Medical Use

Medical Applications

Magnesium sulfate is a critical component in various medical treatments. It is used to treat conditions such as pre-eclampsia and eclampsia in pregnant women, and it also serves as a treatment for constipation and as a muscle relaxant[1][3].

Clinical Studies

While there are numerous studies on the efficacy and safety of magnesium sulfate, specific clinical trials focusing on its formulation in plastic containers are limited. However, the safety of the plastic containers themselves has been evaluated. For instance, biological testing has supported the safety of the syringe material used for magnesium sulfate injections, indicating that the leaching of chemical components from the plastic is minimal and does not pose a significant risk[1].

Storage and Handling

Magnesium sulfate in plastic containers is typically stored at controlled room temperatures (20 to 25°C or 68 to 77°F) and protected from freezing. The containers are designed to prevent significant water permeation and leaching of chemicals, ensuring the stability of the solution over its shelf life[3][5].

Market Analysis

Current Market Size and Growth

The magnesium sulfate market is experiencing robust growth, driven by increasing demand from the agricultural and pharmaceutical sectors. As of 2023, the market is valued at approximately $1 billion and is projected to reach $1.68 billion by 2033, growing at a CAGR of 5.7%[2].

Key Drivers

  • Agricultural Use: Magnesium sulfate is an essential supplement for plant development, aiding in photosynthesis, sugar production, and iron utilization. The integration of magnesium sulfate with other agricultural fertilizers further boosts its demand[2][4].
  • Pharmaceutical Use: The compound's role in treating various medical conditions, including constipation and pre-eclampsia, contributes significantly to its market growth[1][2].
  • Government Regulations: Efforts to reduce plastic consumption and stringent regulations on plastic waste are expected to influence the market positively, as manufacturers adapt to more sustainable packaging solutions[2][4].

End-Use Industries

The demand for magnesium sulfate is driven by several end-use industries:

  • Agriculture: Agriculture-grade magnesium sulfate is crucial for plant nutrition and soil health.
  • Pharmaceuticals: Used in various medical treatments and formulations.
  • Chemicals: Utilized in the production of other chemicals and products.
  • Food and Beverage: Growing demand from this sector is also contributing to the market growth[2][4].

Market Projections

Short-Term Growth (2023-2026)

The market is expected to experience rapid growth during this period, driven by the increasing utilization of magnesium sulfate in chemicals, agriculture, pharmaceuticals, and other industries. This growth will be fueled by expanding agricultural activities and growing demand from the food and beverage sector[2].

Mid-Term Growth (2026-2029)

The mid-term growth will be attributed to the continued expansion in agricultural growth and significant developments in end-use industries. The integration of magnesium sulfate with other agricultural fertilizers and its role in improving soil health will remain key drivers[2].

Long-Term Growth (2029-2033)

Long-term growth will be influenced by the focus on reducing plastic consumption and adhering to stringent government regulations. As manufacturers adapt to more sustainable packaging solutions, the market is expected to thrive at a steady CAGR of 5.7%[2][4].

Impact of Government Regulations

Government initiatives to reduce plastic waste and promote sustainable practices are expected to shape the future of the magnesium sulfate market. Manufacturers will need to comply with regulations aimed at minimizing environmental impact, which could lead to innovations in packaging and production processes[2][4].

Conclusion

Magnesium sulfate in plastic containers is a vital product with diverse applications. The market is poised for significant growth, driven by agricultural, pharmaceutical, and chemical industries. As the world moves towards more sustainable practices, the magnesium sulfate market is expected to adapt and thrive.

Key Takeaways

  • Robust Market Growth: The magnesium sulfate market is projected to grow at a CAGR of 5.7% from 2023 to 2033.
  • Diverse Applications: Key uses include agriculture, pharmaceuticals, and chemicals.
  • Sustainability Focus: Government regulations on plastic waste will influence market trends.
  • Agricultural Importance: Magnesium sulfate is crucial for plant development and soil health.
  • Pharmaceutical Significance: Used in various medical treatments, including pre-eclampsia and constipation.

FAQs

What are the primary uses of magnesium sulfate?

Magnesium sulfate is primarily used in agriculture as a plant nutrient, in pharmaceuticals for treating conditions like pre-eclampsia and constipation, and in the chemical industry for various applications.

How is magnesium sulfate packaged?

Magnesium sulfate is often packaged in single-dose flexible plastic containers, which are designed to prevent significant water permeation and leaching of chemicals.

What is the projected market size of magnesium sulfate by 2033?

The magnesium sulfate market is expected to reach $1.68 billion by 2033, growing at a CAGR of 5.7% from 2023[2].

What are the key drivers of the magnesium sulfate market?

Key drivers include increasing demand from agricultural and pharmaceutical sectors, integration with other agricultural fertilizers, and government regulations aimed at reducing plastic waste.

How does government regulation impact the magnesium sulfate market?

Government regulations on reducing plastic consumption and waste are expected to influence the market positively, driving innovations in sustainable packaging and production processes.

Sources

  1. Pfizer: Magnesium Sulfate Injection, USP 50% - Labeling Information.
  2. Future Market Insights: Magnesium Sulfate Market - Growth Drivers & Opportunities.
  3. Pfizer Medical Information: Magnesium Sulfate in Water for Injection - Storage and Handling.
  4. Fact.MR: Magnesium Sulphate Market Size & Growth Analysis.
  5. Baxter: Magnesium Sulfate in 5% Dextrose Injection, USP - Product Information.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.